When was IRIDEX founded?

IRIDEX was founded in 1989 and raised its 1st funding round 36 years after it was founded.

Where is IRIDEX located?

IRIDEX is headquartered in Mountain View, United States. It is registered at Mountain View, California.

How many employees does IRIDEX have?

As of Sep 30, 2026, the latest employee count at IRIDEX is 183.

Is IRIDEX a funded company?

IRIDEX is a funded company, having raised a total of $***** in its 1st and only funding round, a Post IPO round on Mar 19, 2025.

When was the latest funding round of IRIDEX?

IRIDEX's latest funding was a $***** Post IPO round on Mar 19, 2025, with participation from 0 investor. Its primary sector is Diversified Medical Devices. In United States, the Diversified Medical Devices sector has seen $353M in funding in 2026 to date.

What is the annual revenue of IRIDEX?

Annual revenue of IRIDEX is between $50M and $100M as on Jan 03, 2026

Where does IRIDEX rank among its competitors?

IRIDEX ranks 2nd amongst 79 active competitors, of which 10 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was IRIDEX, which secured $10M in Mar, 2025.

Who are the top competitors of IRIDEX?

IRIDEX's top competitors include MicroSurgical Technology, Perfuse Therapeutics and Ziemer Ophthalmology. Among them, IRIDEX secured the most recent funding round in March, 2025.

IRIDEX - 2026 Company Profile, Funding, Competitors & Financials

Company Details

Manufacturer of ophthalmic laser systems and surgical instruments for eyes. These medical devices support the treatment of retinal diseases and glaucoma through traditional and tissue-sparing laser technology. The product portfolio includes delivery devices, endoscopic probes, and consumables designed for use in office settings and surgical facilities.

Website: iridex.com
Social
Email ID: *****@iridex.com
Phone Number: +1 **********
Registered Address: Mountain View, California

Key Metrics

Founded Year

1989

Location

Mountain View, United States

Stage

Public

Latest Funding Round

Post IPO, Mar 19, 2025, $*****

Investors

Incubic & 2 more

Ranked

2^nd among 79 active competitors

Annual Revenue

$50M - $100M as on Jan 03, 2026

Employee Count

183 as on Sep 30, 2026

Similar Companies

MicroSurgical Technology & 89 more

Exit Details

Public

View IRIDEX's full profile

IRIDEX is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
IRIDEX CORP CIN: 1006045 , United States, Active	Nov 20, 1995	$50M - $100M (As on Jan 03, 2026)	130 (As on Dec 31, 2022)	-
Iridex Corporation CIN: 770210467 , United States, Active	Dec 26, 999	-	104 (As on Dec 31, 2024)	-

IRIDEX got listed on Feb 15, 1996.

Click here to take a look at IRIDEX's IPO in detail

IRIDEX has raised funding over 1 round. IRIDEX has 3 institutional investors.

Here is the list of recent funding rounds of IRIDEX:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 19, 2025	3981526	Post IPO	6877154	3345405	1227108	2271740

Access funding benchmarks and valuations. Sign up today!

View details of IRIDEX's funding rounds and investors

IRIDEX's employee count trend

IRIDEX has 183 employees as of Sep 26. Here is IRIDEX's employee count trend over the years:

Uncover IRIDEX's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of IRIDEX include MicroSurgical Technology, Perfuse Therapeutics and Ziemer Ophthalmology. Here is the list of Top 10 competitors of IRIDEX, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	MicroSurgical Technology 1976, Redmond (United States), Acquired	Develops a portfolio of Surgical tools for Ophthalmic surgeries	-	-	50/100
2nd	IRIDEX 1989, Mountain View (United States), Public	Manufacturer of ophthalmic laser systems and surgical instruments for eyes	-	Incubic, Technology Partners & 1 others	50/100
3rd	Perfuse Therapeutics 2018, San Francisco (United States), Acquired	Developer of therapies to treat eye disorders	-	Access Industries, Lilly Asia Ventures & 3 others	46/100
4th	Ziemer Ophthalmology 2005, Basel (Switzerland), Series B	Portfolio of devices for refractive and corneal surgery	$17.4M	BV Partners, HBM Partners & 1 others	44/100
5th	Oertli Instrumente 1955, Berneck (Switzerland), Unfunded	Developer of ophthalmology medical device	-	-	44/100
6th	Quantel Medical 1993, Cournon (France), Series C	Ultrasound and Laser devices for opthalmology	$13.7M	-	43/100
7th	Dopavision 2017, Berlin (Germany), Series A	Developer of a digital therapeutic for myopia	$17.4M	Boehringer Ingelheim Venture Fund, Seventure Partners ... & 9 others	43/100
8th	Lamellar 2007, Glasgow (United Kingdom), Series C	Develops patented medical devices and pharmaceuticals based on mimetics of extra-alveolar lamellar bodies	$18.4M	Hambro Perks, Invesco & 4 others	42/100
9th	Katena 1975, Tampa (United States), Acquired	Ophthalmic surgical products for sight restoration, clinician support, and patient care	$7.5M	Audax Private Equity	40/100
10th	Biotech Vision Care 1998, Ahmedabad (India), Unfunded	Developer of ophthalmic surgical and eye care products	-	-	40/100